SynopsisWarts that don't respond to standard therapies may be treated with prescription drugs. The topical immunotherapy drug imiquimod (Aldara), a standard therapy for genital warts, can also be used to treat skin warts. The global Drugs for Warts market size i.....
SynopsisCalcium hydroxide is normally used as slurry of Calcium hydroxide in a water base. At body temperature less than 0.2% of Calcium hydroxide is dissolved into ca++ and OH- ions.The value of calcium hydroxide in endodontic treatment of necrotic infected teeth is .....
SynopsisEye Wash Station is a unit that attaches to a water supply and provides a gentle stream of water; used for emergency irrigation to remove contaminants from the ocular area. The global Eyewash Station market size is expected to reach US$ 122.1 million by .....
SynopsisIt was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS). The global L.....
SynopsisCefaclor, sold under the trade name Ceclor among others, is a second-generation cephalosporin antibiotic used to treat certain bacterial infections such as pneumonia and infections of the ear, lung, skin, throat, and urinary tract. The global Cefaclor ma.....
SynopsisMedical lasers are medical devices that use precisely focused light sources to treat or remove tissues. The term “laser” stands for light amplification by stimulated emission of radiation The global Medical Lasers market size is expected to reach US$ 134.....
SynopsisCephalexin is a cephalosporin (SEF a low spor in) antibiotic. It works by fighting bacteria in your body. The global Cephalexine market size is expected to reach US$ 205.4 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainl.....
SynopsisA splint is a piece of medical equipment used to keep an injured body part from moving and to protect it from any further damage. The global Stabilization Splint market size is expected to reach US$ 2280.2 million by 2029, growing at a CAGR of 5.7% from .....
SynopsisAdenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide. The global Adenosine Deaminase Deficiency Treatment market size is expected to reach U.....
SynopsisAcute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It.....
